Duke University's nationally-leading HIV vaccine research consortium, operating since 2005 with several vaccine candidates approaching clinical trial phase, is losing major NIH funding support. The funding discontinuation represents a substantial setback for domestic HIV therapeutic development efforts.
Search
Congressional trades, bills, prediction markets, hearings, and intelligence signals. Signal search supports: AND OR "exact phrase" -exclude
59,107 signals for Health+Cyber+Supply Chain
Page 15 of 2365